NLGIA
AGN

Nippon Life Global Investors Americas’s Allergan plc AGN Stock Holding History

Nippon Life Global Investors Americas’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,700
Closed -$3.38M – 153
2019
Q4 		$3.38M Hold
17,700
– – 0.23% 101
2019
Q3 		$2.98M Sell
17,700
-11,800
-40% -$1.92M 0.22% 105
2019
Q2 		$4.94M Buy
+29,500
New +$4.08M 0.38% 75
2018
Q4 		– Sell
-48,390
Closed -$9.22M – 152
2018
Q3 		$9.22M Buy
48,390
+4,290
+10% +$788K 0.7% 45
2018
Q2 		$7.35M Buy
44,100
+5,260
+14% +$844K 0.58% 53
2018
Q1 		$6.54M Sell
38,840
-6,600
-15% -$1.11M 0.54% 58
2017
Q4 		$7.43M Buy
45,440
+19,150
+73% +$3.44M 0.59% 57
2017
Q3 		$5.39M Buy
26,290
+4,180
+19% +$972K 0.46% 70
2017
Q2 		$5.37M Hold
22,110
– – 0.46% 78
2017
Q1 		$5.28M Sell
22,110
-14,340
-39% -$3.34M 0.47% 81
2016
Q4 		$7.66M Buy
36,450
+6,720
+23% +$1.39M 0.71% 51
2016
Q3 		$6.85M Buy
+29,730
New +$7.26M 0.65% 54

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nippon Life Global Investors Americas's AGN Position: Q1 2020 in Review

Nippon Life Global Investors Americas sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 17,700 shares — an estimated $3.38M sold.

Nippon Life Global Investors Americas first reported a position in AGN in Q3 2016 and held it in 12 quarters. The position peaked at $9.22M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Nippon Life Global Investors Americas reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 17,700 Allergan plc shares in Q1 2020, an estimated $3.38M.
  • Nippon Life Global Investors Americas first reported a position in Allergan plc in Q3 2016 and held it in 12 quarters.
  • Nippon Life Global Investors Americas's Allergan plc position peaked at $9.22M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2020, filed 15 May 2020.